What are the key insights from ASCO 2025 on ovarian cancer?

Описание: ARTICLE: https://oncologytube.com/ovarian-canc...
Explore key ovarian cancer treatment advancements from Dr. Joshua G. Cohen, M.D., F.A.C.O.G., F.A.C.S., Medical Director of the Gynecologic Cancer Program at City of Hope Orange County, at the MOASC Spotlight 2025 on September 09, 2025, 01:29 PM PDT. This video covers innovative therapies and strategies improving patient outcomes:

Low-Grade Serous Ovarian Cancer: Discover the RAMP 301 trial's 'significant benefit in KRAS mutated patients' and the 'first in class novel combination' of abibitnib and deactnib.

Relacorilant Progress: Learn about 'significant overall survival benefit' with Relacorilant, a new selective receptor antagonist for platinum-resistant cases.

Surgical Expertise: Understand the TRUST trial’s insight: 'the better the surgery, the better the outcome' with a gynecologic oncologist.
PARP Inhibitors: See how 'we may be curing some patients' with initial management strategies.

Presented at the Medical Oncology Association of Southern California (MOASC) Spotlight 2025, this talk offers valuable insights. Read more at https://oncologytube.com/ovarian-canc.... Join MOASC at https://moasc.org/join to stay updated on oncology research.

Timestamps

0:00 - Introduction: Overview of Ovarian Cancer Treatment Advancements
Covers the start of the presentation (00:00:00,000).
0:55 - Low-Grade Serous Ovarian Cancer: RAMP 301 Trial Insights
Highlights "significant benefit in KRAS mutated patients" (00:00:55,555) and the novel combination (00:00:43,576).
1:26 - Relacorilant: Improving Survival in Platinum-Resistant Cases
Focuses on "significant overall survival benefit" with Relacorilant (00:01:26,085) and its mechanism (00:01:35,562).
2:49 - TRUST Trial: The Importance of Optimal Surgery
Addresses "the better the surgery, the better the outcome" (00:02:49,302) and surgical expertise (00:00:29,629).
3:53 - PARP Inhibitors: Enhancing Initial Management
Explores "we may be curing some patients" (00:03:53,266) and initial use (00:03:21,634).

Video interviews to be posted from this event at these websites...
https://oncologytube.com/tag/moasc/
https://moasc.org/

About OncologyTube.com:
OncologyTube.com is a free video-sharing platform dedicated to oncology professionals, offering cancer research updates through videos, audio, PowerPoint presentations, and more. Visit OncologyTube.com for a detailed web post on this and many other cancer topics and oncology insights.

Follow OncologyTube:
eNewsletter: https://oncologytube.com/newsletter/
Twitter:   / oncologytube  
LinkedIn:   / oncologytube-com  
Facebook:   / oncologytube  
Instagram:   / oncologytube  
YouTube:    / oncologytube  

Connect with Us:
Share your thoughts in the comments! Join the discussion.